Bank Julius Baer & Co. Ltd, Zurich Organovo Holdings, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$1.71 - $3.71 $702 - $1,524	-411 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.08 - $8.92 $91 - $133	-15 Reduced 3.52%	411 $3,000
Q2 2021 Jul 23, 2021	BUY	$6.65 - $9.95 $99 - $149	15 Added 3.65%	426 $4,000
Q1 2021 May 10, 2021	BUY	$8.67 - $21.7 $34 - $86	4 Added 0.98%	411 $4,000
Q4 2020 Feb 24, 2021	BUY	$7.19 - $17.05 $2,796 - $6,632	389 Added 2161.11%	407 $5,000
Q4 2020 Feb 12, 2021	SELL	$7.19 - $17.05 $2,825 - $6,700	-393 Reduced 95.62%	18 $5,000
Q3 2020 Nov 10, 2020	BUY	$6.27 - $15.8 $2,576 - $6,493	411 New	411 $3,000

Ticker ONVO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,712,020
Market Cap $3.75M
Description
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.